Searched for
EPILEPSY TREATMENT DRUG
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Indoco Remedies gets USFDA nod to sell generic epilepsy medicineIndoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to trea...
- Akumentis Healthcare launches drug for treatment of epilepsy"We understand the immense physical and emotional toll that frequent seizures can have on patients and their families," Akumentis Executive...
- Zydus Cadila gets USFDA tentative nod for epilepsy treatment drugZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...
- Natco Pharma launches epilepsy treatment drug Brivaracetam in IndiaThe company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing.
- Sun Pharma to launch complete range of generic anti-epilepsy drugThe drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solut...
- Unichem Labs gets USFDA nod to market generic capsulesThe company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg fr...
- JB Chemicals gets USFDA nod to market generic epilepsy drugJB Chemicals and Pharmaceuticals on Monday said it has received approval from the US health regulator to market Carbamazepine extended rele...
- Made-in-India drugs to be based on weed soonThe move to produce medicine formulations that incorporate hemp lend a fresh reputation to the otherwise controversial cannabis
- Good news for epileptic patients: Implanting new device in brain can prevent seizuresThe researchers used a neurotransmitter which acts as the 'brake' at the source.
- Planned pregnancy can help 90% epileptic women have healthy babiesNew Delhi, Nov 19 (IANS) Planned pregnancy can help 90 per cent of epileptic women deliver healthy babies, said doctors.
- FDA approves first 3D-printed drugIn a world first, the US has approved a 3D-printed drug to treat certain types of seizures in epilepsy patients.
- Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tabletsThis ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.
- SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 croreELEPSIA XR is indicated for adjunctive therapy in the treatment of partial onset seizures in patients of 12 years of age and older with epi...
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- Delhi High Court comes to Intas rescue, stops Arinna Lifescience for trademark violationDelhi High Court gave relief to Ahmedabad-based drug maker, Intas Pharmaceuticals, by granting an ex-parte injunction against the sale of V...
- Ranbaxy, Aurobindo get US FDA nod for epilepsy drugPharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets, used in the treatment of epilepsy.
Load More
